M. Levy et al., EVALUATION IN PATIENTS WITH ALPORT SYNDROME OF KNOWLEDGE OF THE DISEASE AND ATTITUDES TOWARD PRENATAL-DIAGNOSIS, Clinical nephrology, 42(4), 1994, pp. 211-220
Cloning of the COL4A5 gene has now made possible prenatal testing for
Alport syndrome with X-linked dominant inheritance. We interviewed 27
females and 24 males with Alport syndrome to evaluate their knowledge
of the disease and its transmission, and their attitudes to prenatal t
esting. Twenty-two males and 8 females were on renal replacement thera
py. In all cases transmission was compatible with X-linked disease. On
ly 59% of the interviewees (74% of women, 42% of men) knew that gender
was the major determinant in progression of the disease. Knowledge of
the mode of inheritance was adequate in only 25%, in both sexes. Seve
nty percent of the participants (78% of women, 63% of men) would use p
renatal testing. Of the women in favor of prenatal diagnosis, 67% and
39% would terminate pregnancy in the case of an affected male or femal
e fetus, respectively. Of the men in favor of prenatal diagnosis, 53%
would consider termination of an affected fetus. In summary, a majorit
y would use prenatal testing, but only one or two thirds of them wishe
d to use selective abortion. As in other inherited disorders, there is
a discrepancy between the demand for prenatal diagnosis and the decis
ion to terminate pregnancy. Most of the participants who would termina
te a pregnancy had, however, little knowledge of the clinical and gene
tic aspects of Alport syndrome on which to base such a decision. An im
portant aspect of genetic counselling is to assist consultants in reac
hing a decision regarding future reproductive behaviour which is appro
priate to their situation. This study underlines the need to improve e
ducation and conselling to assure appropriate use of prenatal testing.